Abbott Laboratories (XETRA: ABL.DE) Stock Competitors & Peer Comparison
See ABL.DE's competitors and their performance on the XETRA and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ABL.DE and its XETRA peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ABL.DE | €89.60 | +1.98% | 155B | 23.41 | €3.83 | +2.36% |
| 2M6.DE | €80.98 | +0.42% | 103.7B | 17.05 | €4.75 | +3.04% |
| SYK.DE | €240.30 | -1.86% | 91.8B | 25.47 | €9.40 | +1.25% |
| SHL.DE | €37.77 | -1.69% | 42.3B | 16.08 | €2.35 | +2.65% |
| PHI1.DE | €21.51 | -0.05% | 21B | 16.91 | €1.27 | +3.95% |
| DRW3.DE | €114.00 | -0.87% | 2.1B | 12.51 | €9.11 | +1.99% |
| DRW8.DE | €85.80 | -0.92% | 2.1B | 9.44 | €9.09 | +1.99% |
| SBS.DE | €24.25 | +0.83% | 294.8M | 34.37 | €0.71 | +2.47% |
| GME.DE | €2.45 | +0.00% | 13.3M | 3.89 | €0.63 | +4.08% |
| E8X.DE | €0.14 | +1.45% | 1.5M | -1.08 | -€0.13 | N/A |
Stock Comparison
Medtronic Plc (XETRA: 2M6.DE)
ABL.DE vs 2M6.DE Comparison September 2026
Abbott Laboratories (XETRA: ABL.DE) plays a significant role within the Healthcare sector. Its performance on the XETRA reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABL.DE stands at 155B. In comparison, 2M6.DE has a market cap of 103.7B. Regarding current trading prices, ABL.DE is priced at €89.60 on the XETRA, while 2M6.DE trades at €80.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABL.DE currently has a P/E ratio of 23.41, whereas 2M6.DE's P/E ratio is 17.05. In terms of profitability, ABL.DE's ROE is +0.11%, compared to 2M6.DE's ROE of +0.11%. Regarding short-term risk, ABL.DE is more volatile compared to 2M6.DE. This indicates higher risk in terms of short-term price fluctuations for ABL.DE.Check 2M6.DE's competition here